Comparison

[Gly22]-β-Amyloid (1-42), Arctic Mutation - 0.5 mg

Item no. AS-61967-05
Manufacturer AnaSpec
Amount 0.5 mg
Category
Type Peptides
Format Lyophilized
Specific against other
Purity Peak Area by HPLC ≥95%
Sequence H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
Citations Yamamoto, N. et al. J. Biol. Chem. 282, 2646 (2007), Van Nostrand, W. et al. J. Biol. Chem. 276, 32860 (2001).
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias DAEFRHDSGYEVHHQKLVFFAGDVGSNKGAIIGLMVGGVVIA
Shipping Condition Room temperature
Available
Manufacturer - Type
Catalog
Manufacturer - Category
Peptides
Manufacturer - Targets
beta-amyloid; beta-amyloid (1-42)
Shipping Temperature
RT
Storage Conditions
- 20 °C
Molecular Weight
4442.4
Description
This is amino acids 1 to 40 fragment of the mutant form of beta-amyloid, with glycine substituted for glutamic acid at position 22 found in "Arctic" heredity. A toxic soluble beta-amyloid assembly (TA-beta) is formed more rapidly from 'Arctic' beta-amyloid than from wild-type beta-amyloid in the presence of liposomes containing GM1 ganglioside.
Product Group
LB1A3Z
Research Area
Neuroscience / Lyophilized
Sequence One-Letter Code
DAEFRHDSGYEVHHQKLVFFAGDVGSNKGAIIGLMVGGVVIA
GTIN
5400535150327
Usage
Research use
UNSPSC
12352202

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close